Literature DB >> 17227207

Comparison of the proteome of isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis.

Xin Jiang1, Wenhong Zhang, Feng Gao, Yishu Huang, Chong Lv, Honghai Wang.   

Abstract

In an effort to determine whether there is a major difference in protein level between isoniazid resistant and susceptible Mycobacterium tuberculosis strains, the proteins extracted from nine isoniazid (INH) monoresistant M. tuberculosis strains, seven isoniazid susceptible M. tuberculosis strains, and M. tuberculosis H37Rv, were analyzed by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). In all protein spot differences, five protein spots that are upregulated in INH-resistant strains were identified as Rv1446c, Rv3028c, Rv0491, Rv2971, and Rv2145 by matrix-assisted laser desorption/ionization-time of fight-mass spectrometry (MALDI-TOF-MS). Most of these differential proteins are membrane proteins, which are known to be rich in potential diagnostic and therapeutic protein targets. These results suggest that the differentially expressed proteins from INH-resistant strains might be used as potential immunodiagnosis antigens and candidate novel drug targets against drug-resistant tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17227207     DOI: 10.1089/mdr.2006.12.231

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  20 in total

1.  MDR-TB Antibody Response (Western Blot) to Fractions of Isoniazid and Rifampicin Resistant Antigens of Mycobacterium tuberculosis.

Authors:  Alireza Hadizadeh Tasbiti; Shamsi Yari; Mostafa Ghanei; Mohammad Ali Shokrgozar; Ahmadreza Bahrmand
Journal:  Curr Microbiol       Date:  2015-08-28       Impact factor: 2.188

2.  Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis.

Authors:  Carolina Mehaffy; Ann Hess; Jessica E Prenni; Barun Mathema; Barry Kreiswirth; Karen M Dobos
Journal:  Proteomics       Date:  2010-05       Impact factor: 3.984

3.  Using a Label Free Quantitative Proteomics Approach to Identify Changes in Protein Abundance in Multidrug-Resistant Mycobacterium tuberculosis.

Authors:  Truong Quoc Phong; Do Thi Thu Ha; Uwe Volker; Elke Hammer
Journal:  Indian J Microbiol       Date:  2015-01-18       Impact factor: 2.461

4.  Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis.

Authors:  Prashant Sharma; Bhavnesh Kumar; Yash Gupta; Neelja Singhal; Vishwa Mohan Katoch; Krishnamurthy Venkatesan; Deepa Bisht
Journal:  Proteome Sci       Date:  2010-11-18       Impact factor: 2.480

5.  Application status of MALDI-TOF mass spectrometry in the identification and drug resistance of Mycobacterium tuberculosis.

Authors:  Ruixue Zhang; Yin Long; Wenfang He; Xiaoke Hao; Jiayun Liu
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

6.  Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates.

Authors:  Neelja Singhal; Prashant Sharma; Manish Kumar; Beenu Joshi; Deepa Bisht
Journal:  Proteome Sci       Date:  2012-03-01       Impact factor: 2.480

7.  Proteomics of multidrug resistant Mycobacterium tuberculosis clinical isolates: a peep show on mechanism of drug resistance & perhaps more.

Authors:  Kishore Parsa; Seyed E Hasnain
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

8.  Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant.

Authors:  Amit Singh; Krishnamoorthy Gopinath; Prashant Sharma; Deepa Bisht; Pawan Sharma; Niti Singh; Sarman Singh
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

9.  Comparing mRNA expression and protein abundance in MDR Mycobacterium tuberculosis: Novel protein candidates, Rv0443, Rv0379 and Rv0147 as TB potential diagnostic or therapeutic targets.

Authors:  Alireza Hadizadeh Tasbiti; Shamsi Yari; Seyed Davar Siadat; Morteza Karimipoor; Farzad Badmasti; Morteza Masoumi; Farid Abdolrahimi; Sharareh Khanipour; Seyed Mehdi Hassanzadeh; Mostafa Ghalami Nobar; Fatemeh Yari
Journal:  Biotechnol Rep (Amst)       Date:  2021-05-29

10.  Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data.

Authors:  Josephine M Bryant; Anita C Schürch; Henk van Deutekom; Simon R Harris; Jessica L de Beer; Victor de Jager; Kristin Kremer; Sacha A F T van Hijum; Roland J Siezen; Martien Borgdorff; Stephen D Bentley; Julian Parkhill; Dick van Soolingen
Journal:  BMC Infect Dis       Date:  2013-02-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.